Data gathered: October 25
Alternative Data for Bristol-Myers Squibb
About Bristol-Myers Squibb
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
| Price | $43.83 |
| Target Price | Sign up |
| Volume | 9,990,000 |
| Market Cap | $89.2B |
| Year Range | $42.73 - $60.77 |
| Dividend Yield | 5.54% |
| PE Ratio | 17.6 |
| Analyst Rating | 33% buy |
| Earnings Date | October 30 '25 |
| Industry | Drug Manufacturers |
In the news
 |
Does Bristol-Myers Squibb’s 22% Drop in 2024 Suggest an Opportunity for Investors?October 23 - Yahoo |
 |
Bristol-Myers Squibb: This High FCF Yield Is The Best Value In HealthcareOctober 23 - SeekingAlpha |
|
Analyst Says Bristol-Myers Squibb (BMY) Among the Best ‘Deep Value’ Stocks to BuyOctober 23 - Yahoo |
|
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out forOctober 23 - Yahoo |
|
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on ItOctober 22 - Yahoo |
|
Bristol Myers Squibb (BMY) Stock Moves 2.18%: What You Should KnowOctober 21 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 12.3B | 4.2B | 8.07B | 1.31B | 3.29B | 1.460 |
| Q1 '25 | 11.2B | 3.86B | 7.34B | 2.46B | 4.48B | 1.800 |
| Q4 '24 | 12.3B | 4.92B | 7.42B | 72M | 2.55B | 1.670 |
| Q3 '24 | 11.9B | 5.28B | 6.62B | 1.21B | 4.77B | 1.800 |
| Q2 '24 | 12.2B | 5.4B | 6.8B | 1.68B | 4.4B | 2.070 |
Insider Transactions View All
| Elkins David V filed to sell 167,379 shares at $47.3. September 3 '25 |
| Short Bartie Wendy filed to sell 5,066 shares at $44.2. August 5 '25 |
| Hirawat Samit filed to buy 83,513 shares at $47.6. April 29 '25 |
| BOERNER CHRISTOPHER S. filed to buy 104,626 shares at $55. February 21 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$190.4 0% | 63 |
 |
Eli Lilly and CompanyLLY |
$825.45 0% | 59 |
 |
PfizerPFE |
$24.76 0% | 62 |
 |
AstrazenecaAZN |
$83.29 0% | 59 |
 |
AbbVieABBV |
$227.99 0% | 64 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Valerie Hoyle |
Sep 12, 25 | Buy | $1K - $15K |
| Julie Johnson |
Sep 12, 25 | Sell | $1K - $15K |
| Virginia Foxx |
Jul 4, 25 | Sell | $1K - $15K |
Read more about Bristol-Myers Squibb (BMY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Bristol-Myers Squibb?
The Market Cap of Bristol-Myers Squibb is $89.2B.
What is Bristol-Myers Squibb's PE Ratio?
As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 17.6.
When does Bristol-Myers Squibb report earnings?
Bristol-Myers Squibb will report its next earnings on October 30 '25.
What is the current stock price of Bristol-Myers Squibb?
Currently, the price of one share of Bristol-Myers Squibb stock is $43.83.
How can I analyze the BMY stock price chart for investment decisions?
The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.
Does BMY offer dividends to its shareholders?
Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 5.54%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bristol-Myers Squibb?
Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.
